Abstract
Bronchiolitis is a common lung infection in young children and infants. It causes inflammation and congestion in the small airways (bronchioles) of the lung. Bronchiolitis is almost caused by a virus. Bronchodilators are medication which makes breathing easier by relaxing the muscles in the lungs and widening airways. To assess the efficacy and risk associated with the use of bronchodilators in pediatric patients with bronchiolitis. To assess the Efficacy of Bronchodilators, to evaluate the risk associated with bronchodilators in bronchiolitis patients and to evaluate the patient compliance in patients using bronchodilator for bronchiolitis. This study was conducted in 10 bronchiolitic pediatric patients. This study was conducted by categorizing the patients according to their Respiratory Rate, SpO2 and Heart Rate values. Patient compliance is analyzed using CRS scale and risk is assessed with Wang Scale. Keywords: Bronchiolitis, Bronchodilators, Levosalbutamol
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
